Pfizer
Pfizer head joins UK biotech Calchan
May 19, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, calhan, zahid ali
UK-based biotech Calchan has looked to Pfizer for appointing a new chief scientific officer in Zahid Ali. Ali has almost …
Pharma M&A trail continues as Pfizer buys slice of Dutch biotech
May 12, 2015Sales and Marketing Endo, Pfizer, aspen, merger
Pfizer has acquired a minority equity interest in the biotech firm AM-Pharma, and secured an exclusive option to acquire the …
Reputation gains from focussing on the patient
May 11, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, HIV, Manuel Goncalves, Pfizer, ViiV
Since being spun-off from GSK and Pfizer, specialist HIV firm ViiV Healthcare has earned the best corporate reputation amongst patients …
Pfizer names new R&D leaders
May 7, 2015Research and Development, Sales and Marketing John Lin, Michael Ehlers, Pfizer, rinat
Pfizer has confirmed two key appointments to lead its worldwide research and development organisation with immediate effect. The firm will …
Pfizer posts second consecutive quarterly income decline
April 29, 2015Sales and Marketing 2015, Pfizer, Q1, first quarter
Pfizer made 4% less revenue in the first quarter of 2015 compared with the same period last year, the company’s …
Two oncology successes for Pfizer
April 22, 2015Research and Development, Sales and Marketing Cancer, FDA, Inotuzumab ozogamicin, NSCLC, Pfizer, Xalkori, oncology
Pfizer has received two boosts in oncology as Xalkori gets a new breakthrough therapy designation from the FDA, and its …
Merck KGaA and Pfizer alliance begins lung cancer study
April 21, 2015Research and Development, Sales and Marketing Merck KGaA, Pfizer, avelumab, keytruda, oncology, opdivo
Merck KGaA and Pfizer have enrolled and treated the first patient in a late-stage study of their anti-PD1 cancer immunotherapy …
Round one to Pfizer in Zoloft lawsuit battle
April 20, 2015Sales and Marketing Pfizer, Zoloft, antidepressant, birth defects, law suits, legal, sertraline
Pfizer’s Zoloft did not cause a young boy’s birth defects, a jury has ruled, in the first of a thousand …
Pfizer breast cancer trial stopped following promising results
April 15, 2015Sales and Marketing ASCO, FDA, Pfizer, ibrance, palbociclib
Regulators have stopped a Phase III clinical trial of Pfizer’s Ibrance early after it demonstrated improved survival in women with …
Manufacturing woes hit Baxter again
April 14, 2015Manufacturing and Production, Sales and Marketing FDA, Gemünden, Pfizer, alesse, baxter, manufacturing, recall, vectura group
Baxter is voluntarily recalling several lots of intravenous solutions due to the potential presence of particulate matter. The news has …
Pfizer launches cardiovascular research competition
April 10, 2015Research and Development, Sales and Marketing Amgen, Astellas, LDL, PCSK9, Pfizer, bococizumab, inhibitors
Pfizer is funding a new competitive grants programme to support research projects in the burgeoning, competitive area of cholesterol-lowering PCSK9 …
Merck and Pfizer to co-promote cancer drug
April 9, 2015Research and Development, Sales and Marketing Cancer, Merck, Merck KGaA, NSCLC, Pfizer, Xalkori, non-small cell lung cancer, oncology
Merck KgaA and Pfizer have agreed to co-promote the latter’s lung cancer treatment Xalkori, and form a new alliance that …
Pfizer appoints inflammation and immunology head
April 1, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Charles Reay Mackay, Pfizer
Professor Charles Reay Mackay is joining US pharma giant Pfizer as the chief scientific officer of its inflammation and immunology …
Pfizer is pharma’s biggest advertiser
March 31, 2015Medical Communications, Sales and Marketing AbbVie, AstraZeneca, Pfizer, advertising, adverts, dtc, lilly
US giant Pfizer spends far more on direct-to-consumer advertising than any other pharma firm according to new data from Kantar …
Funding boost for UK drugs manufacturing
March 30, 2015Manufacturing and Production, Sales and Marketing ABPI, AstraZeneca, BIA, Bristol-Myers Squibb, Britest, Cambridge, Cambridge Crystallographic Data Centre, GlaxoSmithKline, Perceptive Engineering, Pfizer, Process Systems Enterprise, UCB, University of Leeds, amsci, mmip, stfc
The UK government is funding new manufacturing partnerships that will improve design processes and supply chain initiatives to lift the …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
